Become a credit card member today!Prascend (pergolide tablets) 1 mg, Count of 160
Description
PRASCEND (pergolide tablets) is the most proven treatment available to control the clinical signs associated with PPID in horses (formerly known as equine Cushings disease).1 PRASCEND is a rectangular light red colored, half-scored tablet containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only.1 PRASCEND (pergolide tablets) (Freedom of Information Summary). St Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011. IMPORTANT SAFETY INFORMATION PRASCEND (pergolide tablets) has not been evaluated in breeding, pregnant or lactating horses. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. If severe, a temporary dose reduction may be necessary. PRASCEND tablets should not be crushed due to the potential for increased human exposure. Keep PRASCEND in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Dogs have eaten PRASCEND tablets that were placed.
- - By using PRASCEND (pergolide tablets) as part of your pituitary pars intermedia dysfunction (PPID) management protocol, you can help reduce the signs of PPID and improve horses quality of life.
- - Horses treated with PRASCEND showed improved clinical signs within 3 months and continued through 6 months
- - 3 out of 4 horses evaluated were considered treatment successes
- - Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 3442082 |
|---|---|
| Primary Brand | Prascend |
| Days to Ship | Ships Next Business Day |
| Personalized Item flag | No |
|---|
Administer PRASCEND (pergolide tablets) orally at a starting dose of 2 mcg/kg once daily. Dosage may be adjusted to effect, not to exceed 4 mcg/kg daily. The tablets are scored and the calculated dosage should be provided to the nearest one-half tablet increment. Follow your vets instructions.
Treatment with PRASCEND (pergolide tablets) may cause inappetence. The use of PRASCEND in breeding, pregnant, or lactating horses has not been evaluated. The effects of pergolide mesylate on breeding, pregnant, or lactating horses are not known; however, the pharmacologic action of pergolide mesylate suggests that it may interfere with reproductive functions such as lactation. PRASCEND is approximately 90% associated with plasma proteins. Use caution if administering PRASCEND with other drugs that affect protein binding. Dopamine antagonists, such as neuroleptics (phenothiazines, domperidone) or metoclopramide, ordinarily should not be administered concurrently with PRASCEND (a dopamine agonist) since these agents may diminish the effectiveness of PRASCEND. Keep PRASCEND in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Dogs have eaten PRASCEND tablets that were placed in food intended for horses or dropped during admi.
Description
PRASCEND (pergolide tablets) is the most proven treatment available to control the clinical signs associated with PPID in horses (formerly known as equine Cushings disease).1 PRASCEND is a rectangular light red colored, half-scored tablet containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only.1 PRASCEND (pergolide tablets) (Freedom of Information Summary). St Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2011. IMPORTANT SAFETY INFORMATION PRASCEND (pergolide tablets) has not been evaluated in breeding, pregnant or lactating horses. Treatment with PRASCEND may cause loss of appetite. Most cases are mild. If severe, a temporary dose reduction may be necessary. PRASCEND tablets should not be crushed due to the potential for increased human exposure. Keep PRASCEND in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Dogs have eaten PRASCEND tablets that were placed.
- - By using PRASCEND (pergolide tablets) as part of your pituitary pars intermedia dysfunction (PPID) management protocol, you can help reduce the signs of PPID and improve horses quality of life.
- - Horses treated with PRASCEND showed improved clinical signs within 3 months and continued through 6 months
- - 3 out of 4 horses evaluated were considered treatment successes
- - Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 3442082 |
|---|---|
| Primary Brand | Prascend |
| Days to Ship | Ships Next Business Day |
Reviews
Rating Snapshot
Review this Product
Filter Reviews
Prascend
No, I do not recommend this product.
Questions
How do you want the prescription? Do you want the original put in an envelope and mailed? Or can we email it to you?
- When you place your order, they will request your veterinarian's information inlcuding clinic name and DVM's name. Petco will then contact your veterinarian for approval electronically.
Helpful?
